Assay Detail
Binding
CHEMBL4723488
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Inhibition of envelope protein in HCoV-229E infected in human MRC-5 cells assessed as reduction in viral replication incubated for 6 days by crystal violet staining based plaque reduction assay
1
Total Activities
1
Compounds Tested
1
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Binding |
| Organism | Human coronavirus 229E |
| Cell Type | MRC5 |
| Confidence | 0 — Uncurated / Unknown |
| Curated By | Autocuration |
Publication
Druggable targets from coronaviruses for designing new antiviral drugs.
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| EC50 | 1 | 5.87 | 5.87 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL501701 | N,N-HEXAMETHYLENEAMILORIDE | — | 1 | 5.87 |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL501701 | N,N-HEXAMETHYLENEAMILORIDE | EC50 | = | 1340.0 | nM | 5.87 |